首页 | 本学科首页   官方微博 | 高级检索  
检索        

多西他赛对乳腺癌细胞中Cav-1表达及细胞增殖的影响
引用本文:李 颖,尹良伟,刘基巍,刘 鹏.多西他赛对乳腺癌细胞中Cav-1表达及细胞增殖的影响[J].大连医科大学学报,2017,39(4):318-322.
作者姓名:李 颖  尹良伟  刘基巍  刘 鹏
作者单位:1. 大连医科大学附属第一医院 肿瘤一科,辽宁 大连,116011;2. 大连医科大学附属大连市中心医院 肿瘤内科三病房,辽宁 大连,116021
基金项目:基金项目:国家自然科学基金项目(81302310)
摘    要:目的 研究多西他赛对乳腺癌细胞中Cav-1(Cav-1)表达及细胞增殖的影响.方法 通过Real-time PCR和Western-blot检测不同浓度多西他赛作用下乳腺癌细胞MCF-7中Cav-1的表达情况;野生型MCF-7细胞株为对照组,通过基因转染技术建立Cav-1 过表达的MCF-7细胞株(转染组)及空载体的MCF-7细胞株(空载体组),利用CCK-8比色法分析多西他赛对各组细胞增殖的影响.通过Western-blot分别检测多西他赛作用下各组细胞中凋亡相关蛋白Bax和Bcl-2的表达情况以及PI3K/AKT 信号转导通路的活化情况.结果 在5~40 μg/mL浓度范围内,随着多西他赛作用浓度的增大,MCF-7细胞中Cav-1的蛋白表达量逐渐增加.不同浓度多西他赛对MCF-7细胞的增殖均有明显的抑制作用;在同一浓度多西他赛作用下,转染Cav-1组细胞的增殖抑制率明显高于对照组和空载体组(P<0.01).与对照组和空载体组相比,20 μg/mL多西他赛作用后转染组细胞中Bax的表达升高(P<0.01),而Bcl-2的表达降低(P<0.01),并且磷酸化AKT (p-AKT)蛋白的表达水平下降(P<0.01),而对照组和空载体组之间Bax、Bcl-2以及p-AKT蛋白的表达则无明显差异(P>0.05).结论 多西他赛可以通过促进Cav-1的表达影响PI3K/AKT 信号转导通路,进而调节凋亡相关蛋白的表达抑制MCF-7 细胞的增殖.

关 键 词:Cav-1  多西他赛  乳腺癌细胞  细胞增殖  基因治疗
收稿时间:2017/3/20 0:00:00

Effect and potential mechanism of Cav-1 in Docetaxel inhibiting breast cancer MCF-7 cell proliferation
LI Ying,YIN Liangwei,LIU Jiwei and LIU Peng.Effect and potential mechanism of Cav-1 in Docetaxel inhibiting breast cancer MCF-7 cell proliferation[J].Journal of Dalian Medical University,2017,39(4):318-322.
Authors:LI Ying  YIN Liangwei  LIU Jiwei and LIU Peng
Institution:Department of Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China,Department of Oncology, Dalian Municipal Central Hospital Affiliated of Dalian Medical Universty, Dalian 116021, China,Department of Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China and Department of Oncology, Dalian Municipal Central Hospital Affiliated of Dalian Medical Universty, Dalian 116021, China
Abstract:Objective To investigate the effect and potential mechanism of Cav-1 (Cav-1) on the proliferation inhibiting of breast cancer MCF-7 cell by Docetaxel.Methods The transfection group was established by stable transfection of pcDNA3.1-Cav-1 into MCF-7 cells, while the vector group (pcDNA3.1 vector transfected) and control group (non-transfection MCF-7 cells) were used as control.The Cav-1 expression of MCF-7 cells treated by Docetaxel was detected by Real-time PCR and Western-blot.CCK-8 assay was used to analyze the cell proliferation.The expression of Bax and Bcl-2 proteins and the activation of PI3K/AKT signal pathway were examined by Western-blot.Results The expression of Cav-1 in MCF-7 cells was gradually enhanced with the increasing of Docetaxel concentration in the range of 5-40 μg/mL.The inhibitory rate of cell proliferation in Cav-1 transfection group was significantly higher than that of the control groups after Docetaxel treatment (P<0.01).Compared with the control groups, Bax expression increased and Bcl-2 and p-AKT expression decreased in Cav-1 transfection group (P<0.01), while there was no significant difference between the two control groups (P>0.05).Conslusion Docetaxel might inhibit the proliferation of MCF-7 cells by promoting the Cav-1 expression, which can regulate the apoptosis-related protein expression and suppress the activation of PI3K/AKT signaling pathway.
Keywords:Cav-1  Docetaxel  breast cancer cells  cell proliferation  gene therapy
本文献已被 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号